Kelly Tullos
Family Medicine · Laurel, MSNPI 1508125576
Payments from drug & device makers
Across 192 payments — averaging $16.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$679
- AbbVie$592
- Lilly USA, LLC$417
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$231
- Astellas Pharma US Inc$140
- Abbott$112
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,10196%
- Education$1384%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 44 | $679 |
| AbbVie(2 entities) | 42 | $592 |
| Lilly USA, LLC | 28 | $417 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $231 |
| Astellas Pharma US Inc | 9 | $140 |
| Abbott | 7 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $105 |
| Silk Road Medical, Inc. | 1 | $104 |
| Daiichi Sankyo Inc. | 4 | $84 |
| Amgen | 5 | $77 |
| Scilex Pharmaceuticals Inc. | 1 | $73 |
| GSK | 4 | $66 |
| Boehringer Ingelheim | 2 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $61 |
| Novartis | 3 | $59 |
| Merck | 3 | $50 |
| AstraZeneca | 3 | $40 |
| Pfizer | 2 | $35 |
| IBSA Pharma Inc. | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Rhythm Pharmaceuticals, Inc. | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Shield Therapeutics Inc | 1 | $19 |
| Ardelyx, Inc. | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Seqirus USA Inc | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,238 in reported general payments places this provider in the 75th percentile of 971 family medicine providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 519 | $580,562 |
| MounjaroTirzepatide | 326 | $371,322 |
| WegovySemaglutide | 54 | $73,477 |
| LinzessLinaclotide | 78 | $62,784 |
| RybelsusSemaglutide | 27 | $24,937 |
| TrulicityDulaglutide | 13 | $16,537 |
| FarxigaDapagliflozin Propanediol | 16 | $14,399 |
| JardianceEmpagliflozin | 11 | $11,270 |
| Naltrexone Hcl | 41 | $1,426 |
| Ondansetron Hcl | 156 | $1,051 |
| Metformin Hcl ErMetformin Hcl | 384 | $925 |
| Topiramate | 113 | $561 |
| Bupropion Hcl SrBupropion Hcl | 44 | $460 |
| Bupropion XlBupropion Hcl | 27 | $193 |
| Atorvastatin Calcium | 17 | $169 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Wegovy, Rybelsus | $679 | $678,976600 claims |
| Lilly USA, LLCMounjaro, Trulicity | $417 | $387,858339 claims |
| AbbVieLinzess | $592 | $62,78478 claims |
| AstraZenecaFarxiga | $40 | $14,39916 claims |
| Boehringer IngelheimJardiance | $65 | $11,27011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 971 family medicine providers in Mississippi.
Other family medicine in Laurel
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
- Alexander OsowaJackson$2.2M
- Russell CarlisleWesson$1.6M
- Kristi TrimmRidgeland$1.2M
- Keith StokesLexington$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.